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Acute pancreatitis: a complication associated with
rheolytic mechanical thrombectomy of deep
venous thrombosis
Kenneth T. Piercy, MD, Juan Ayerdi, MD, Randolph L. Geary, MD, Kimberley J. Hansen, MD,
and Matthew S. Edwards, MD, Winston-Salem, NC
Percutaneous mechanical rheolytic thrombectomy is increasingly being used for the treatment of arterial, venous, and
graft thromboses. We describe three cases of pancreatitis as a complication of mechanical rheolytic thrombectomy used in
the treatment of caval and ileofemoral deep venous thrombosis and discuss the possible etiologic factors involved. To our
knowledge, this complication has been previously reported in only two cases. ( J Vasc Surg 2006;44:1110-3.)Percutaneous mechanical rheolytic thrombectomy is
rapidly becoming a popular method for the treatment of
vascular thrombosis. Multiple case series and retrospective
analyses have reported its safe and effective use as an adjunct
to traditional anticoagulation for the treatment of iliocaval
deep venous thrombosis (DVT) and arterial and hemodial-
ysis access thromboses.1-5 A number of complications have
been reported, including vessel perforation, dissection, dis-
tal embolization, fluid overload, cardiac arrhythmias, he-
molysis, hemorrhage, and access site complications.1,5-7
This report details another potential complication, acute
pancreatitis, associated with the use of mechanical rheolytic
thrombectomy encountered among three patients present-
ing with iliac or caval DVT.
CASE REPORTS
Patient 1. A healthy 43-year-old woman presented 12 days
after operation from a sling cystourethropexy and cystoscopy for
stress incontinence. After the procedure, she experienced general-
ized muscle aches in her legs, and on postoperative day 4 she
developed a fever to 102° F with chills, worsened left leg joint pain,
and left leg swelling. The patient was seen in the emergency
department and was found to have marked left lower extremity
edema to the level of the groin with hip and thigh tenderness.
Duplex ultrasonography revealed left ileofemoral, femoral,
and popliteal DVT. A computed tomography (CT) scan of the
abdomen revealed a 7-cm  3.5-cm retroperitoneal fluid collec-
tion adjacent to the pelvic sidewall consistent with a hematoma
from the patient’s prior procedure. There was no evidence of active
extravasation, which confirmed the left common iliac vein throm-
bosis. An intravenous heparin infusion was initiated.
From the Division of Surgical Sciences, Section on Vascular and Endovas-
cular Surgery, Wake Forest University School of Medicine.
Competition of interest: none.
Correspondence:MatthewS.Edwards,MD,AssistantProfessorofSurgery,Section
on Vascular and Endovascular Surgery, Division of Surgical Sciences, Wake
ForestUniversitySchoolofMedicine,MedicalCenterBlvd,Winston-Salem,NC
27157-1095 (e-mail: medwards@wfubmc.edu).
0741-5214/$32.00
Copyright © 2006 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2006.06.030
1110The patient was taken to the operating room and placed in the
prone position after general endotracheal anesthesia was induced.
The left popliteal vein was localized using duplex ultrasonography
and percutaneously cannulated, followed by passage of a 0.035-
inch guidewire and placement of a 6F sheath. A venogram con-
firmed thrombosis of the left popliteal, femoral, and iliac veins to
the caval bifurcation.
A power-pulse spray technique8 with the AngioJet DVX cath-
eter (Possis Medical, Minneapolis, Minn) was used to infuse
350,000 units of urokinase (Abbott Laboratories, Abbott Park, Ill)
into the thrombus from the popliteal vein to the caval bifurcation,
which was allowed to dwell for 30 minutes. Multiple passes were
then performed with the AngioJet catheter for mechanical throm-
bectomy. This procedure generated 500 mL of effluent.
A completion venography revealed the establishment of a flow
channel from the popliteal vein to the inferior vena cava (IVC). A
multiple side hole infusion catheter (AngioDynamics, Queensbury,
NY) was placed with side holes extending from the caval bifurcation
to the distal femoral vein. Urokinase was then infused at 200,000
U/h for 1 hour, then decreased to 100,000 U/h for approxi-
mately 18 hours. Heparin (750 U/h) was also administered,
divided equally between a peripheral intravenous and the left
popliteal vein sheath.
The patient returned to the operating room the next day,
where repeat venography revealed near complete lysis of the left
lower extremity DVT with a small region of thrombosis remaining
in the mid left common iliac vein. This region was dilated with a
12-mm 4-cm angioplasty balloon. The patient was also noted to
have a duplicate femoral vein system, with one segment still largely
thrombosed. Postoperatively, the patient was maintained on a
heparin infusion until a therapeutic international normalized ratio
was obtained using warfarin.
Four days after the initial mechanical thrombectomy, abdom-
inal pain and nausea developed. Her serum amylase levels were
normal at 80 U/L (normal: 30 to 120 U/L); however, serum
lipase was elevated at 159 U/dL (normal, 10 to 68 U/dL) and
peaked at 174 U/dL, consistent with mild pancreatitis. An ileus
also developed that required 2 days of bowel rest. The patient had
return of bowel function and toleration of oral intake. She was
discharged to home 5 days postoperatively.
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history presented to the emergency department with a 6-hour
history of massive left lower extremity swelling and tenderness
extending from the ankle to the hip. He denied any history of
trauma or DVT, but reported having taken a 20-hour plane flight
3 weeks previously. A CT scan revealed a thrombosed left iliac
venous system to the junction with the IVC and evidence of a
pulmonary embolus on the inferior cuts of his right pulmonary
vasculature. The patient was given a heparin bolus and a drip was
initiated.
The patient was taken to the operating room and placed in the
prone position after general endotracheal anesthesia was induced.
The IVC was accessed through a sheath placed in the left short
saphenous vein. Venography revealed complete occlusion of the
left common and external iliac veins to the level of the IVC.
The power-pulse spray technique with the AngioJet DVX
catheter was used to infuse 250,000 units of urokinase from the
level of the introducer sheath to the IVC, which was allowed to
dwell for 20 minutes. The AngioJet catheter was then used to
perform mechanical thrombectomy, which generated 400 mL of
effluent.
Completion venography revealed widely patent popliteal and
femoral veins with residual thrombus within the proximal external
iliac and common iliac veins. The iliac vein was very large, with a
diameter of 30 mm. Angioplasty of the left common iliac vein was
performed with a 10-mm  4-cm angioplasty balloon, which
revealed a stenosis with an approximately 4-mm residual flow
channel. This area was then dilated with a 14-mm 4-cm balloon.
Repeat venography revealed persistent thrombus within a par-
tially recanalized common iliac vein. Additional passages through this
segment were then performed with the AngioJet for 150 mL of
additional effluent. Repeat venography revealed improvement in the
left common iliac vein but not complete resolution of thrombus. A
multiple side hole infusion catheter was placed with the side holes
spanning the residual thrombus. Urokinase was infused at 180,000
U/h through the infusion catheter, while the patient received
heparin 750 U/hour through the left short saphenous vein sheath
and 750 U/hour through a peripheral intravenous catheter, with
lytic infusion planned overnight.
That evening the patient experienced acute onset abdominal
pain. A CT scan revealed severe pancreatitis (Fig 1,B) . The uroki-
nase infusion was stopped and the heparin infusion was switched
completely to the left short saphenous sheath. Values for the patient’s
serum amylase and lipase were 1747 U/L and 2430 U/dL, respec-
tively.
The patient returned to the operating room the next day, and
venography revealed widely patient popliteal and femoral veins, as
well as the IVC with continued occlusion of a 6.5-cm segment of
the left common iliac vein. A 16-mm  4-cm angioplasty balloon
was used to angioplasty the left common iliac vein and appeared to
take a waist at its proximal portion.
Intravascular ultrasonography (Boston Scientific, Natick,
Mass) was then performed to try to localize the stenosis and guide
stent placement given the large iliac vein size. This revealed a near
total obliteration of the mid left common iliac vein lumen for a
6-cm length. Two 14-mm  4-cm self-expanding stents (Bard
Luminexx, Covington, Ga) were placed within the left common
iliac vein and were dilated after deployment with a 14-mm 4-cmangioplasty balloon. Completion venography showed the stents to
be widely patent. Postoperatively, the patient was maintained on
heparin at 1800 U/h through a peripheral intravenous catheter.
Because of the pancreatitis, the patient was maintained on
bowel rest and nasogastric tube decompression. Values for serum
amylase and lipase declined over the ensuing days to 220 U/L and
227 U/dL, respectively. An ileus developed and the patient re-
quired the initiation of total parenteral nutrition on postoperative
day 5. His hospital course was further complicated by epistaxis
requiring nasal packing, multiple transfusions, 7-day cessation of
anticoagulation, and placement and removal of an IVC filter. Serial
CT scans revealed the development of two pancreatic pseudocysts
(Fig 1,C and D). The ileus later resolved, and the patient tolerated
enteral nutrition. He was discharged on postoperative day 20 and
maintained on warfarin anticoagulation.
Patient 3. A 67-year-old man transferred to our institution
5 days after a left total knee replacement. The patient had a history
of a right lower extremity DVT with pulmonary embolus after a
right total knee replacement 7 years earlier. He had received a
prophylactic TrapEase (Cordis, Miami Lakes, Fla) IVC filter 5 days
before his left total knee replacement in addition to subcutaneous
heparin for DVT prophylaxis postoperatively.
On postoperative day 2 a massive bilateral lower extremity
edema developed. Duplex scanning revealed bilateral lower ex-
tremity DVT involving the popliteals to the iliac veins bilaterally.
Intravenous heparin was administered at 1200U/h, and a CT scan
was performed to determine the extent of the thrombosis. CT
revealed the thrombosis to involve the IVC to the level of the renal
veins.
The patient was taken to the operating room and, after anes-
Fig 1. Serial computed tomography (CT) scans of patient 2. A,
Scan immediately before mechanical thrombolysis shows normal-
appearing pancreas.B,At approximately 12 hours after mechanical
thrombolysis, scan reveals marked inflammatory changes are
within the pancreas and peripancreatic fluid consistent with acute
pancreatitis. C, CT scan 18 days postoperatively shows decreased
inflammatory changes, organization of the peripancreatic fluid,
and the interval development of two pancreatic pseudocysts. D,
Deceased size of the pancreatic pseudocysts at 46 days postopera-
tively.thetic induction and prone positioning, ultrasonic guidance was
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(0.035 inch) were passed bilaterally to the level of the IVC.
Venography confirmed extensive lower extremity and iliocaval
thrombus to the level of the renal veins. Urokinase (500,000 U)
was administered through power-pulse spray technique with the
AngioJet DVX catheter from the level of the popliteal veins to the
IVC filter and allowed to dwell for 25 minutes. Mechanical throm-
bectomy was then performed using the AngioJet DVX catheter on
the left side, then on the right, both with passage from the level of
the popliteal veins to the IVC for a total effluent of 480 mL.
Repeat venography revealed patent popliteal, femoral, exter-
nal iliac, and common iliac veins bilaterally with a significant
amount of residual thrombus, most of which localized to the iliac
veins and the IVC. Owing to the patient’s recent surgery, lytic
infusion was not performed postoperatively. Heparin was infused
at a total rate of 1800 U/h (600 U/h via each short saphenous
sheath and 600 U/h via a peripheral intravenous catheter). The
short saphenous sheaths were removed the following day, and
heparin (1800 U/h) was continued through a peripheral intrave-
nous catheter. Oral warfarin therapy was initiated.
Later that day, the patient experienced mild abdominal pain
and nausea. Concentrations of serum amylase and lipase were
75 U/L and 112 U/dL, respectively, and increased to 187 U/L
and 335 U/dL. An ileus developed that required bowel rest for 3
days. During this time, the patient’s serum amylase and lipase
normalized. His ileus resolved, and the patient began tolerating
enteral nutrition. He was discharged on postoperative day 18.
DISCUSSION
This report describes three patients, all presenting with
extensive thrombus burden from DVT consistent with
phlegmasia cerulea dolens, who developed acute pancreati-
tis after rheolytic mechanical thrombectomy. None of the
patients had significant underlying medical problems or
conditions predisposing to pancreatitis, none had an under-
lying hypercoagulable state, and only one had a history of
DVT after an orthopedic procedure 7 years earlier. None of
the patients had a history of pancreatitis, and all manifested
clinical pancreatitis hours to days after their mechanical
thrombectomy.
This report represents only the second series of patients
in the literature documenting acute pancreatitis after rheo-
lytic mechanical thrombectomy.9 This previous series de-
scribed two patients, one presenting with acute arterial
bypass graft thrombosis and the other with superior vena
caval and brachiocephalic vein thrombosis. In contradis-
tinction to patients in the current report, both patients had
underlying chronic renal insufficiency that was believed to
predispose to acute pancreatitis; however, as the current
report suggests, underlying renal insufficiency is not re-
quired.
Also, the occurrence of this complication does not
appear to be limited to the use of the relatively new Angio-
Jet DVX catheter, which is the largest rheolytic catheter
made by Possis Medical. The two previously reported cases
used the smaller Angiojet Xpeedior 100 and Angiojet LF
140 catheters.9Additional possible causes for pancreatitis among these
patients include biliary system disease, alcohol consump-
tion, and medications. None of the patients had any clinical
symptoms of biliary disease, and all had normal bilirubin
levels. None of the patients had recently consumed alcohol,
and none had a history of alcohol abuse. Each patient was
maintained on their home medications and only had the
addition of urokinase and heparin. Neither of these agents has
been documented in the literature to induce pancreatitis.
Given the temporal relationship, we speculate the
cause of the pancreatitis to be the hemolysis that ensues
during mechanical thrombectomy, which is a collateral
effect of mechanical thrombectomy.2-4,7,10 The Angio-
Jet rheolytic system functions by using a drive unit to
generate pulsatile high-velocity saline jets, with pressures
upwards of 10,000 psi, that are redirected at the catheter
tip to a retrograde direction creating a low-pressure zone
(Bernoulli-Venturi effect). This low-pressure zone re-
sults in thrombus maceration and evacuation through
the catheter (Fig 2).
The shear forces generated by the saline jets results in
trauma to the red blood cells that leads to hemolysis, as
evidenced by a darkening of the urine indicating hemoglo-
binuria. Hemolysis has been previously described as an
etiology of pancreatitis, with acute pancreatitis developing
secondary to hemolytic transfusion reactions, hemodialysis,
microangiopathic hemolytic anemia, toxemia, glucose-6-
phosphate dehydrogenase deficiency, septic abortion, ma-
laria, Wilson’s disease, hypophosphatemia, autoimmune
hemolytic anemia, and sickle cell anemia.6,11-14
The pathophysiology of acute pancreatitis secondary to
hemolysis is incompletely understood; however, an animal
Fig 2. The AngioJet rheolytic system (Possis Medical, Minneapolis,
Minn) functions by using a drive unit to generate pulsatile high-
velocity saline jets with pressures upwards of 10,000 psi that are
redirected at the catheter tip to a retrograde direction creating a
low-pressure zone (Bernoulli-Venturi effect). This low-pressure
zone results in thrombus maceration and evacuation through the
catheter. (Image reproduced with permission from Possis Medical,
Minneapolis, Minn from www.possis.com.)model has been developed.15 Heme released from hemo-
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process.16 Low levels of heme are normally removed from
the circulation by heme-binding proteins such as he-
mopexin thus preventing initiation of an inflammatory
state. However, massive hemolysis, which may occur as a
result of extended mechanical thrombectomy times, leads
to free heme concentrations that overwhelm the ability of
the heme-binding proteins to counteract. Research has
demonstrated that heme can promote neutrophil activa-
tion, migration, and oxidative burst resulting in oxygen free
radical generation and cytokine production.16 These proin-
flammatory elements have been shown to result in pancre-
atic injury and pancreatitis.17,18
CONCLUSION
This report describes the rare but significant compli-
cation of acute pancreatitis due to mechanical thrombec-
tomy, which led to prolongation of hospital stay and
patient discomfort. However, the pathophysiology and
dose responses are uncertain. Limiting the length of time
that mechanical thrombectomy is performed and the
amount of effluent obtained would appear to be a prudent
practice. The current instructions for use included with the
AngioJet DVX catheter recommend limiting the applica-
tion time in flowing blood to 4 minutes and in thrombosed
vessels to 8 minutes. These limits are based on the use of
this system for arterial and dialysis-access thromboses; the
system is not currently approved by the United States Food
and Drug Administration for use for venous thrombosis.
Unfortunately, the temporal length of device activity is not
currently recorded by the device, and it is difficult to know
whether blood is flowing or thrombosed as vessels are
cleared during application. No specific guidelines for limits
on collected hemolyzed exudate, which is easily assessed
visually, currently exist. Further observation and study may
help to establish such guidelines and to determine whether
or not the addition of this technique to catheter based
thrombolytic therapy is useful or detrimental.
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